Sun Shines on Jacobson MRT Patients in Nassau; Light of Day Finally Comes to 26-Year-Old Discovery
Patients in Nassau, Bahamas have been finding relief from pain and sufferring from Magnetic Resonance Therapy (MRT). "Quality of life" is being restored to folks with diabetic neuropathy, Alzheimer's, headache, fibromyalgia, arthritis, Parkinson's, sciatica and more. MRT has also been proven to be of great benefit in the healing process of sports related injuries. Provider approval has been given by major Bahamian insurance providers and MRT is supported by rigorous and relavent scientific studies at major American institutions including Cornell University, Fairleigh Dikinson University, University of Oklahoma and more.
Boca Raton, FL (PRWEB) August 3, 2005 -- Foundation for Jacobson Resonance
(FJR) -- How is it possible -- in our world of instant communication, where
everything from tropical depressions to tsunamis to terrorist tragedies can
garner the attention of the entire world -- filling our ears, eyes and minds in
literally moments -- it can take 26 long years for a potentially revolutionary
scientific discovery to finally surface and command the attention it truly
deserves.
Over the last 20 months, Dr. Jerry I. Jacobson and his Magnetic
Resonance Therapy (MRT) have been successfully treating people in Nassau, New
Providence, Bahamas. Treated patients have found relief from pain and suffering
caused by a wide variety of aliments and afflictions including: diabetic
neuropathy, ALS, headache, fibromyalgia, arthritis, Parkinson's, sciatica,
Alzheimer's and more… restoring a "quality of life" where there was once no
hope. MRT has also been proven to be of great benefit in the healing process of
sports related injuries. Testimony to the method's veracity is the provider
approval given to it by major Bahamian insurance carriers.
Subjected to a
series of rigorous and relevant scientific studies over decades, Jacobson's MRT
has been validated time and time again. Prof. Brij Saxena, Weill Medical College
of Cornell University (nerve growth, repair and functional recovery in mice);
Prof. Ben Scherlag, University of Oklahoma (suppression of certain cardiac
arrhythmias in dogs); Prof. Anjali Saxena, Fairleigh Dickinson University (nerve
growth, repair and functional recovery in mice). And, a yet to be published
in-vitro study that inhibited the growth of human female breast cancer cells at
the Mississippi State University's School of Veterinary
Medicine.
Application of the therapy is facilitated through a device
called a Resonator, which in the case of those being used in the Nassau
facility, were built at the Stennis Space Center by NASA subcontractors. The
design structure is such that no part of the Resonator touches the body while
the therapy is being administered. This incorporation of its unique dual coil
technology allows for a completely non-invasive and totally safe process.
Health Canada issued licensing rights for Resonators to be used in the
reduction of pain associated with arthritic conditions. European CE-Mark
approval was granted for both the production of Resonators and their use in the
reduction of chronic pain associated with arthrosis of the knee. In both
instances the Resonators may be used for relaxation purposes. Since February of
2004 the Resonators have been used in the USA to “enhance feelings of
relaxation.”*
For further information please contact Harvey Grossman,
Founder & President of the Foundation for Jacobson Resonance at
1.877.439.0514 in North America, and at 561.208.1775 from outside North America.
The Foundation for Jacobson Resonance (FJR), founded in 1995, is a
501(c)(3) tax-exempt charitable organization whose mission is to support
education and research in Jacobson Resonance and other related worthy causes.
Throughout the years FJR has sponsored educational forums, public informational
media campaigns, mailing campaigns, fundraising events and has granted funds for
research purposes.
*On February 17, 2004 Section 513(g) of the Federal
Food, Drug and Cosmetic Act (Act) responded to the request to use the Jacobson
Resonator to “enhance feelings of relaxation.” The Center for Devices and
Radiological Health (CDR1-1) does not intend to enforce pre-market requirements
on the Jacobson Resonator. This enforcement discretion applies to this type of
device only when it is labeled solely to “enhance feelings of
relaxation.”
# # #
Source : http://www.prweb.com/releases/2005/8/prweb267944.htm